RiverPark Advisors’s Transmedics TMDX Stock Holding History

RiverPark Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-675	Closed	-$67.1K	–	153
2026 Q1	$67.1K	Sell	675 -9	-1%	-$1.17K	0.02%	126
2025 Q4	$83.2K	Buy	684 +298	+77%	+$37.4K	0.02%	125
2025 Q3	$43.3K	Sell	386 -577	-60%	-$67.5K	0.02%	122
2025 Q2	$129K	Buy	+963	New	+$106K	0.08%	90
2025 Q1	–	Sell	-293	Closed	-$118K	–	147
2024 Q4	$118K	Sell	293 -3,404	-92%	-$317K	0.09%	98
2024 Q3	$580K	Sell	3,697 -765	-17%	-$118K	0.47%	49
2024 Q2	$672K	Sell	4,462 -1,620	-27%	-$194K	0.56%	45
2024 Q1	$450K	Buy	6,082 +4,763	+361%	+$393K	0.37%	56
2023 Q4	$104K	Buy	1,319 +215	+19%	+$13K	0.1%	54
2023 Q3	$60.4K	Buy	+1,104	New	+$79.5K	0.05%	63

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

RiverPark Advisors's TMDX Position: Q2 2026 in Review

RiverPark Advisors sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 675 shares — an estimated $67.1K sold.

RiverPark Advisors first reported a position in TMDX in Q3 2023 and held it in 10 quarters. The position peaked at $672K in Q2 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

RiverPark Advisors reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
RiverPark Advisors sold 675 Transmedics shares in Q2 2026, an estimated $67.1K.
RiverPark Advisors first reported a position in Transmedics in Q3 2023 and held it in 10 quarters.
RiverPark Advisors's Transmedics position peaked at $672K in Q2 2024.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on RiverPark Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.